FDA Inspection 1310492 — BEIJING HUAN QIU LI KANG BIOTECH CO., LTD.
The FDA completed an inspection of BEIJING HUAN QIU LI KANG BIOTECH CO., LTD. on Apr 2, 2026 in Beijing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 2, 2026
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Project Evaluation: Devices
- Location
- Beijing (China)